243 related articles for article (PubMed ID: 30430714)
1. Barrett's oesophagus: A qualitative study of patient burden, care delivery experience and follow-up needs.
Britton J; Hamdy S; McLaughlin J; Horne M; Ang Y
Health Expect; 2019 Feb; 22(1):21-33. PubMed ID: 30430714
[TBL] [Abstract][Full Text] [Related]
2. Effect of diagnosis, surveillance, and treatment of Barrett's oesophagus on health-related quality of life.
Britton J; Keld R; Prasad N; Hamdy S; McLaughlin J; Ang Y
Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):57-65. PubMed ID: 28970029
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic surveillance for Barrett's oesophagus: the patients' perspective.
Cooper SC; El-agib A; Dar S; Mohammed I; Nightingale P; Murray IA; Cooper BT; Trudgill NJ
Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):850-4. PubMed ID: 19598328
[TBL] [Abstract][Full Text] [Related]
4. Quality of life measures in dysplastic Barrett's oesophagus are comparable to patients with non-dysplastic Barrett's oesophagus and do not improve after endoscopic therapy.
Ratcliffe E; Britton J; Heal C; Keld R; Murgatroyd M; Willert R; McLaughlin J; Hamdy S; Ang Y
BMJ Open Gastroenterol; 2023 Apr; 10(1):. PubMed ID: 37041020
[TBL] [Abstract][Full Text] [Related]
5. Developing patient-orientated Barrett's oesophagus services: the role of dedicated services.
Ratcliffe E; Britton J; Hamdy S; McLaughlin J; Ang Y
BMJ Open Gastroenterol; 2022 Feb; 9(1):. PubMed ID: 35193888
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
7. Barrett's oesophagus: an audit of surveillance over a 17-year period.
Gladman L; Chapman W; Iqbal TH; Gearty JC; Cooper BT
Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):271-6. PubMed ID: 16462540
[TBL] [Abstract][Full Text] [Related]
8. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
[TBL] [Abstract][Full Text] [Related]
9. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.
Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW;
Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191
[TBL] [Abstract][Full Text] [Related]
10. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
[TBL] [Abstract][Full Text] [Related]
11. Research priority setting in Barrett's oesophagus and gastro-oesophageal reflux disease.
Britton J; Gadeke L; Lovat L; Hamdy S; Hawkey C; McLaughlin J; Ang Y
Lancet Gastroenterol Hepatol; 2017 Nov; 2(11):824-831. PubMed ID: 28867477
[TBL] [Abstract][Full Text] [Related]
12. Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus.
Holmberg D; Ness-Jensen E; Mattsson F; El-Serag HB; Lagergren J
Eur J Cancer; 2017 Apr; 75():41-46. PubMed ID: 28214656
[TBL] [Abstract][Full Text] [Related]
13. Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years.
Hage M; Siersema PD; van Dekken H; Steyerberg EW; Dees J; Kuipers EJ
Scand J Gastroenterol; 2004 Dec; 39(12):1175-9. PubMed ID: 15742992
[TBL] [Abstract][Full Text] [Related]
14. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
Armstrong D
Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
[TBL] [Abstract][Full Text] [Related]
15. Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance.
Rana PS; Johnston DA
Dis Esophagus; 2000; 13(1):28-31. PubMed ID: 11005328
[TBL] [Abstract][Full Text] [Related]
16. A surveillance programme for Barrett's oesophagus in a UK general hospital.
Olithselvan A; Gorard DA; McIntyre AS
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
[TBL] [Abstract][Full Text] [Related]
17. Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression.
Kastelein F; van Olphen SH; Steyerberg EW; Spaander MC; Bruno MJ;
Gut; 2016 Apr; 65(4):548-54. PubMed ID: 25903690
[TBL] [Abstract][Full Text] [Related]
18. Perceptions of risk and therapy among patients with Barrett's esophagus: a patient survey study.
Stier MW; Lodhia N; Jacobs J; Nozicka D; Kavitt R; Siddiqui U; Waxman I; Konda VJ
Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036278
[TBL] [Abstract][Full Text] [Related]
19. The evolution and outcome of surveillance of Barrett's oesophagus over four decades in a UK District General Hospital.
Royston C; Caygill C; Charlett A; Bardhan KD
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1365-1373. PubMed ID: 27571366
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma risk in patients registered with Polish Barrett's Oesophagus Registry.
Januszewicz W; Kaminski MF; Wieszczy P; Wronska E; Bielasik A; Wojciechowska U; Didkowska J; Orlowska J; Regula J
Dis Esophagus; 2017 Jan; 30(1):1-6. PubMed ID: 27377059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
